First Time Loading...
Y

YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558

Watchlist Manager
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Watchlist
Price: 13 HKD -0.46% Market Closed
Updated: May 5, 2024

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Y
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Operating Income
¥2.9B
CAGR 3-Years
60%
CAGR 5-Years
22%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Income
¥787.7m
CAGR 3-Years
32%
CAGR 5-Years
24%
CAGR 10-Years
N/A

See Also

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income?
Operating Income
2.9B CNY

Based on the financial report for Dec 31, 2023, YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income amounts to 2.9B CNY.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
22%

Over the last year, the Operating Income growth was 145%. The average annual Operating Income growth rates for YiChang HEC ChangJiang Pharmaceutical Co Ltd have been 60% over the past three years , 22% over the past five years .